Supplemental Table S2 from FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

• DOI: 10.1158/1078-0432.22472894.v1
• Publication Date: 2023-04-01T01:37:09Z
• Authors: Aviva C. Krauss; Xin Gao; Liang Li; Michael L. Manning; Paresma Patel; Wentao Fu; Kumar G. Janoria; Gerlie Gieser; David A. Bateman; Donna Przepiorka; Yuan Li Shen; Stacy S. Shord; Christopher M. Sheth; Anamitro Banerjee; Jiang Liu; Kirsten B. Goldberg; Ann T. Farrell; Gideon M. Blumenthal; Richard Pazdur
• Keywords: Cytopenia; Daunorubicin

<p>Supplemental Table 2: Prolonged Cytopenia on Study 301</p>